PSDV Insider Trading Activity and SEC Form 4 Filings
PSDV insider trading summary
No open-market insider purchases or sales of EyePoint Pharmaceuticals, Inc. (PSDV) have been reported on SEC Form 4 in the past 12 months.
Latest PSDV insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 28, 2018 | Essex Woodlands IX, LLC | 10% Owner | Buy | $9.1M (8,273,461 @ $1.10) |
| Mar 28, 2018 | Essex Woodlands Fund IX-GP, L.P. | 10% Owner | Buy | $366K (332,863 @ $1.10) |
| Mar 28, 2018 | Essex Woodlands IX, LLC | 10% Owner | Buy | $366K (332,863 @ $1.10) |
| Mar 28, 2018 | EW Healthcare Partners, L.P. | 10% Owner | Buy | $366K (332,863 @ $1.10) |
| Mar 28, 2018 | EW Healthcare Partners, L.P. | 10% Owner | Buy | $9.1M (8,273,461 @ $1.10) |
| Mar 28, 2018 | EW Healthcare Partners-A, L.P. | 10% Owner | Buy | $366K (332,863 @ $1.10) |
| Mar 28, 2018 | EW Healthcare Partners-A, L.P. | 10% Owner | Buy | $9.1M (8,273,461 @ $1.10) |
| Mar 28, 2018 | Essex Woodlands Fund IX-GP, L.P. | 10% Owner | Buy | $9.1M (8,273,461 @ $1.10) |
| Jun 14, 2017 | Nancy Lurker | President and CEO | Buy | $100K (56,700 @ $1.76) |
| Jan 4, 2016 | Leonard S Ross | Vice President, Finance | Sell | $24K (5,000 @ $4.70) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.